HF
FBIO icon

HRT Financial’s Fortress Biotech FBIO Stock Holding History

HRT Financial’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-46,130
Closed -$170K – 3402
2025
Q3 		$170K Buy
+46,130
New +$117K ﹤0.01% 2440
2023
Q4 		– Sell
-804
Closed -$3K – 2535
2023
Q3 		$3K Buy
+804
New +$5.52K ﹤0.01% 2218

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

HRT Financial's FBIO Position: Q4 2025 in Review

HRT Financial sold out of Fortress Biotech (FBIO) in Q4 2025, closing a stake of 46,130 shares — an estimated $170K sold.

HRT Financial first reported a position in FBIO in Q3 2023 and held it in 2 quarters. The position peaked at $170K in Q3 2025. 52 funds tracked by Wall St. Rank hold FBIO as of Q4 2025.

  • HRT Financial reported no remaining Fortress Biotech position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 46,130 Fortress Biotech shares in Q4 2025, an estimated $170K.
  • HRT Financial first reported a position in Fortress Biotech in Q3 2023 and held it in 2 quarters.
  • HRT Financial's Fortress Biotech position peaked at $170K in Q3 2025.
  • 52 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.